Stem cells
Research shows neonatal stem cells could be used as treatment for Crohn’s disease
July 31, 2023Research and Development Crohn’s disease, Gastrointestinal tract, Stem cells, gastrointestinal
Recent studies from the Ann & Robert H Lurie Children’s Hospital in Chicago have discovered that human neonatal cardiac-derived mesenchymal …
Bone regeneration stem cell “putty” sees positive results in trials
June 15, 2021Manufacturing and Production Cell regeneration, Stem cells, bone, platform, technology
Belgian clinical stage company, Novadip Biosciences, has announced positive results from its Phase I trial of its autologous cell-based osteogenic …
Rinri Therapeutics secures £3.2 million grant for hearing loss therapy
May 13, 2021Stem cells
Sheffield-based biotech company, Rinri Therapeutics, have secured a £3.2 million grant from Innovate UK to further develop Rinri’s novel stem …
Diabetes drug could increase stem cells in the womb to treat recurrent miscarriage
January 9, 2020Business Services Stem cells, diabetes, insulin, miscarraiges, pregnancy
A study led by the University of Warwick found that sitagliptin, a diabetes drug, could be used to treat recurrent …
San Francisco scientists use CRISPR to develop stem cells invisible to the immune system
February 19, 2019Manufacturing and Production Nature Biotechnology, Stem cells, UC San Francisco, iPSCs, regenerative medicine
Scientists at UC San Francisco have used the gene editing tool CRISPR Cas9 to manufacture pluripotent stem cells (stem cells …
Stem cells could ‘reset’ immune system in Crohn’s disease patients
August 8, 2018Research and Development Crohn’s disease, Stem cells, crohn's disease, trials
A clinical trial led by researchers at Queen Mary University, London is looking into ways in which patients with Crohn’s …
FDA launches lawsuits against stem cell clinics after patients rendered blind
May 10, 2018Medical Communications, Sales and Marketing FDA, Stem cells, US, macular degeneration, pharma
At the request of the FDA, The US Department of Justice has launched legal action seeking to shut down stem …
Lilly’s arthritis drug found to prevent potentially lethal stem cell transplant complications
April 25, 2018Research and Development Cancer, Eli Lilly, JAK inhibitors, Stem cells, baricitinib, graft-versus-host disease, pharma
Researchers at St Louis Washington University School of Medicine have uncovered a promising extra application of a particular Janus Kinase …
“Game-changer” stem cell transplant shows strength in multiple sclerosis
March 19, 2018Research and Development, Sales and Marketing Stem cells, multiple sclerosis, pharma
A new stem cell transplant is being hailed as a “game-changer” in the treatment of multiple sclerosis (MS) after an …
Stem cell therapy fails to improve symptoms of peripheral artery disease
November 16, 2017Research and Development Stem cells, peripheral artery disease, pharma, stem cell therapy, trial failure
A new study has revealed that a promising stem cell therapy failed to improve ability to walk in patients with …
Manufacture of red blood cells possible after research breakthrough
March 27, 2017Manufacturing and Production, Research and Development Stem cells, University of Bristol
Researchers from the University of Bristol and NHS Blood and Transplant have managed to perfect a technique whereby it is …
TiGenix announces success of novel heart attack stem cell trial
March 13, 2017Research and Development, Sales and Marketing Stem cells, TiGenix, heart attack
Belgium’s TiGenix has announced the success of its top-line Phase 2/3 study investigating the effects of donor-derived expanded cardiac stem …
Precious Cells Group appoints David Huse in expansion push
December 15, 2015Medical Communications, Research and Development Stem cells, precious cells group
Precious Cells Group, a UK-based international provider of stem cell storage and related technologies, has announced the appointment of commercial …
Astellas to acquire Ocata Therapeutics in $379m buyout
November 11, 2015Research and Development, Sales and Marketing Astellas, Ocata, Stem cells, cell therapy, ophthalmology
Astellas Pharma has agreed to buy Ocata, a firm specialising in cloning and embryonic stem cell therapies, for $379 million. …
£3 million government boost for stem cells
March 26, 2015Research and Development, Sales and Marketing NHS Blood and Transplant, Stem cells, UK, george freeman, government
The UK government will invest £3 million to further improve the provision of stem cells in the UK which will …
